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What is already known on this topic  
 Postnatal deranged glucose homeostasis is common in infants with hypoxic ischaemic 
encephalopathy; the relationship with long-term outcome is unclear.  
 Previous studies have found univariable associations with hypoglycaemia and 
hyperglycaemia and long-term outcome, but not after multivariable analysis.  
What this study adds  
 This study reports that hypoglycaemia and hyperglycaemia during the early postnatal 
period in infants with hypoxic ischaemic encephalopathy are associated with 
unfavourable outcome at 18 months.  
 These associations remained significant after adjusting for birth weight, Apgar score, pH, 
Sarnat stage, and hypothermia therapy. 
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 The odds of an unfavourable outcome were higher in infants with hypoglycaemia 
(OR=6.2), hyperglycaemia (OR=2.7), and any glucose derangement (OR=3) compared 
with normoglycaemic infants. 
 
ABSTRACT 
 
Objective: To investigate the association of neonatal hypoglycaemia and hyperglycaemia with 
outcomes in infants with hypoxic ischaemic encephalopathy (HIE).  
Design: Post hoc analysis of the CoolCap Study.  
Setting: 25 perinatal centres in UK, USA, and New Zealand during 1999–2002.  
Patients: 234 infants at ≥36 weeks' gestation with moderate-to-severe HIE enrolled in the 
CoolCap Study. 214 (91%) infants had documented plasma glucose and follow-up outcome data. 
Intervention: Infants were randomised to head cooling for 72 hours starting within 6 hours of 
birth, or standard care. Plasma glucose levels were measured at pre-determined time intervals 
after randomisation.  
Main outcome measure: The unfavourable primary outcome of the study was death and/or 
severe neurodevelopmental disability at 18 months. Hypoglycaemia (≤40 mg/dL, ≤2.2 mmol/L) 
and hyperglycaemia (>150 mg/dL, >8.3 mmol/L) during the first 12 hours after randomisation 
were investigated for univariable and multivariable associations with unfavourable primary 
outcome.  
Results: 121 (57%) infants had abnormal plasma glucose values within 12 hours of 
randomization. Unfavourable outcome was observed in 126 (60%) infants, and was more 
common among subjects with hypoglycaemia (81%, p=0.004), hyperglycaemia (67%, p=0.01), 
and any glucose derangement within the first 12 hours (67%, p=0.002) compared with 
normoglycaemic infants (48%) in univariable analysis. These associations remained significant 
after adjusting for birth weight, Apgar score, pH, Sarnat stage, and hypothermia therapy.  
Conclusions: Both hypoglycaemia and hyperglycaemia in infants with moderate-to-severe HIE 
were independently associated with unfavourable outcome. Future studies are needed to 
investigate the prognostic significance of these associations and their role as biomarkers of brain 
injury. 
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INTRODUCTION 
 
Hypoxic ischaemic encephalopathy (HIE) is one of the most serious perinatal complications, 
and remains associated with a high risk of death or long-term neurodisability. Despite advances 
in obstetric care, moderate-to-severe HIE affects 1.5–3 per 1000 term live births in developed 
countries.[1, 2] There is now compelling evidence that mild hypothermia induced within 6 hours 
after resuscitation can improve long-term survival without disability.[3] However, many infants 
still die or survive with disability, and recent data suggest that longer or deeper cooling did not 
reduce death at hospital discharge.[4] Thus, it is important to investigate whether other factors 
may help to further optimize care. 
Glucose is the primary substrate for energy metabolism in the newborn brain, and deranged 
metabolism may contribute to neuronal injury.[5, 6] At birth, the continuous transplacental 
infusion of glucose ends; normal postnatal glucose homeostasis then depends on hepatic 
glycogen reserves, hormonal regulation, and external provision of enteral or parenteral substrate. 
Hypoglycaemia and hyperglycaemia occur frequently in infants with HIE, likely due to the 
profound metabolic and hormonal disturbances.[7-9] Their effect on long-term outcome is 
unclear. Although one study found that early hypoglycaemia was a risk factor for short-term 
perinatal brain injury in newborns with HIE,[9] others did not find a relationship between early 
hypoglycaemia and adverse neurodevelopmental outcome at 24 months age after adjusting for 
HIE severity.[7] Two retrospective studies reported conflicting results on the association 
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between early hyperglycaemia and unfavourable outcome in infants with HIE.[7, 10] Thus, there 
is no conclusive evidence that deranged glucose metabolism in infants with HIE is independently 
associated with unfavourable long-term neurologic outcome. 
Animal studies support the potential for neuronal injury from deranged glucose homeostasis 
in the setting of asphyxia. Induced hypoglycaemia decreased the cerebrovascular response to 
hypoxia, increased cerebral superoxide production and aspartate levels in the brain extracellular 
space, and promoted neuronal necrosis.[11-14] Hyperglycaemia before acute hypoxia-ischaemia 
or ischaemia markedly increased brain injury in animal models.[15-17] 
We therefore examined the hypothesis that early transient or recurrent hypoglycaemia (≤40 
mg/dL, ≤2.2 mmol/L)[8] and hyperglycaemia (>150 mg/dL, 8.3 mmol/L)[7] in infants with 
moderate-to-severe HIE would be independently associated with death or severe 
neurodevelopmental disability (primary unfavourable outcome) in a post-hoc analysis from the 
CoolCap Study.[18]  
5 
 
METHODS 
Subjects 
The CoolCap Study was a multicentre randomised controlled study of selective head cooling 
and mild systemic hypothermia for the treatment of perinatal moderate-to-severe HIE in 234 
infants at ≥36 weeks’ gestation enrolled between 1999 to 2002.[18] This study was performed in 
25 perinatal centres using a trial design registered with the US Food and Drug Administration 
under the Investigational Device Exemption/Premarket Approval program. The institutional 
review board at each centre approved the protocol, and written informed consent was obtained 
from parents before randomization. Study subjects were randomised to head cooling for 72 hours 
starting within 6 hours of birth, with rectal temperature maintained at 34.5±0.5C, followed by 
rewarming over 4 hours, or standard care at 37.0±0.5C. The primary unfavourable study 
outcome was death or severe disability (i.e., Gross motor function classification system level 3–
5, Bayley scales of infant development II mental developmental index <70, or bilateral cortical 
visual impairment) at 18 months. CoolCap Study subjects were eligible (n=215, 92 %) for the 
current analysis if they completed follow-up evaluations and plasma glucose values were 
available in the database (figure 1).  
Plasma glucose levels, at pre-defined time points (0, 4, 8, 12, 24, 48, and 72 hours from 
randomisation) were analysed to investigate the association between derangements in glucose 
homeostasis with the primary unfavourable outcome. Demographic and perinatal data, included 
birth weight, gestational age, gender, race, mode of delivery, pregnancy complications, and 
Apgar scores at 1 and 5 minutes. Other clinical data were first pH, modified Sarnat and Sarnat 
stage at randomisation,[19] age at study randomisation, treatment with hypothermia or 
conventional therapy, presence of seizures, death, and Bayley Scales of Infant Development II 
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mental developmental index scores at 18 months. Infants were randomised at a median of 4.8 
(IQR: 4.1–5.3) hours after birth in the CoolCap Study. For the purposes of this study, time points 
refer to the period after randomisation, and not hours of life.[18]  
 
Statistical analysis 
Demographic, obstetric, and neonatal parameters were stratified by primary outcome 
(favourable vs unfavourable) and compared using chi-square test, Fisher’s exact test, t-test, or 
Wilcoxon rank sum test as appropriate. Episodes of hypoglycaemia, normoglycaemia, and 
hyperglycaemia as single or recurrent occurrences during the first 12 hours were documented for 
all subjects. Multiple logistic regression models were built to investigate the association between 
deranged glucose values and an unfavourable outcome. Covariates with p<0.1 from univariable 
analysis were included a priori in the multiple regression models. Statistical significance for the 
final models was assessed at the 0.05 level, and no adjustment was made for multiple hypothesis 
testing in this exploratory analysis. Statistical analysis was conducted using Stata version 12.1 
(StataCorp LP, College Station, TX USA, 2011).
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RESULTS 
Study demographic data stratified by 18-month outcome are shown in table 1. Infants with an 
unfavourable outcome were generally larger, less likely to have been cooled, had more severe vs. 
moderate HIE, had lower 5-minute Apgar scores, and were more acidotic. Incidentally, only 4 
study infants had septicaemia. Therefore, meaningful statistical associations between septicaemia 
and glucose derangements and outcome could not be established.  
Table 1 Baseline characteristics of infants from the CoolCap Study 
*Delivery complications include prolapsed cord, true knot in the cord, umbilical cord tear, 
shoulder dystocia, placental abruption, feto-maternal bleeding, ruptured uterus, antepartum 
haemorrhage, traumatic instrument delivery, head entrapment, and others. 
 
Early postnatal glucose profile 
The time period after randomisation that was most informative for predicting an 
unfavourable outcome was during the first 12 hours. At the time of randomisation, of infants 
with recorded plasma glucose levels, 7% (15/205) were hypoglycaemic and 34% (70/205)  were 
hyperglycaemic. During the first 12 hours, 13% (27/214) of infants had at least one episode of 
Characteristics 
 
n (%) 
All subjects Favourable 
outcome 
Unfavourable 
outcome 
p Value 
215 85 (39.5%) 130 (60.5%) 
Birth weight, mean (SD), g 3445 (646) 3295 (625) 3544 (643) 0.006 
Hypothermia treatment, n (%) 107 (50%) 49 (58%) 58 (45%) 0.06 
Severe HIE, n (%) 74 (35%) 15 (18%) 59 (46%) <0.001 
Male, n (%) 114 (53%) 44 (52%) 70 (54%) 0.77 
Caesarean delivery, n (%) 149 (69%) 64 (75%) 85 (65%) 0.12 
Delivery complications*, n (%) 174 (81%) 66 (78%) 108 (83%) 0.32 
White race, n (%) 136 (63%) 54 (64%) 82 (63%) 0.95 
Apgar 5 minutes, median [IQR] 3 [0–4] 3 [1–4] 2 [0–4] 0.02 
pH, mean (SD) 6.88 (0.22) 6.95 (0.22) 6.83 (0.21) <0.001 
8 
 
hypoglycaemia, 48% (102/214) had at least one episode of hyperglycaemia, and 57% (121/214) 
had ≥1 episode(s) of hypoglycaemia or hyperglycaemia (table 2). Of 207 infants who had ≥1 
glucose values obtained during the first 12 hours, 30% had ≥2 deranged values and 8% had both 
hypoglycaemia and hyperglycaemia. The incidence of hypoglycaemia and hyperglycaemia 
progressively decreased over time during the 72-hour study period. Later (>12 hours after 
randomisation) glucose derangements were not associated with outcome. 
Table 2 Univariable analysis of association of deranged glucose parameters with unfavourable 
outcome 
 
Deranged glucose 
parameter within first 
12 hours after 
randomisation 
n Infants 
with 
deranged 
glucose 
n (%) 
Unfavourable 
outcome among 
infants with 
deranged glucose 
           (%) 
Unfavourable  
outcome among 
normoglycaemic  
infants 
(%) 
p Value 
 
Hypoglycaemia 214a 27 (13) 22/27 (81) 45/93 (48) 0.004 
Hyperglycaemia 214 102 (48) 68/102 (67) 45/93 (48) 0.01 
Hypoglycaemia and/or 
hyperglycaemia 
214 121 (57) 84/121 (69) 45/93 (48) 0.002 
Both hypoglycaemia and 
hyperglycaemia 
207b 8 (4) 6/8 (75) 42/88 (48) 0.27 
Recurrent hypoglycaemia 207 11 (5) 9/11 (82) 42/88 (48) 0.052 
Recurrent 
hyperglycaemia 
207 39 (19) 30/39 (77) 42/88 (48) 0.002 
Recurrent 
hyperglycaemia or 
hypoglycaemia 
207 63 (30) 50/63 (79) 42/88 (48) <0.001 
a1 infant did not have any documented glucose within first 12 hours. 
b7 infants had only single glucose values within the first 12 hours. 
 
Univariable analysis 
Relationship between deranged glucose at individual time points (0, 4, 8, and 12 hours) and 
unfavourable outcome 
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At the time of randomisation, 9% and 41% of infants with unfavourable outcome had 
hypoglycaemia or hyperglycaemia, respectively, compared to 5% and 24% of infants with 
favourable outcome (p=0.011). Derangements of glucose at 4 and 8 hours were significantly 
more common in infants with unfavourable outcome (figure 2). 
Relationship between hypoglycaemia within 12 hours and unfavourable outcome 
Infants with at least one episode of hypoglycaemia during the first 12 hours were more likely 
to have an unfavourable outcome. Among the 27 infants with hypoglycaemia within 12 hours, 22 
(81%) had an unfavourable outcome at 18 months of age compared to only 48% of infants with 
normoglycaemia (p=0.004, table 2).  
Relationship between hyperglycaemia within 12 hours and unfavourable outcome 
Infants with at least one episode of hyperglycaemia during the first 12 hours were also more 
likely to have an unfavourable outcome. Among the 102 infants with hyperglycaemia within 12 
hours, 68 (67%) had an unfavourable outcome, significantly higher than normoglycaemic infants 
(p=0.01, table 2).  
Relationship between recurrent glucose derangements and unfavourable outcome 
Recurrent hypoglycaemia (>1 episode within the first 12 hours) was present in only 11 (5%) 
of the infants; 82% of these infants had an unfavourable outcome, compared to 48% among 
normoglycaemic infants (p=0.052, table 2). Recurrent hyperglycaemia (>1 episode within the 
first 12 hours) was noted in 19% (39/207) of the infants; 77% of these infants had an 
unfavourable outcome compared with 48% among infants with normoglycaemia (p=0.002, table 
2).  
Multivariable analysis 
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Glucose derangements were significant independent predictors of unfavourable outcome 
after adjusting for birth weight, hypothermia therapy, Sarnat stage (III vs II), Apgar score at 5 
minutes, and first pH (table 3). The odds of an unfavourable outcome were 6.2 times greater 
among infants with at least one episode of hypoglycaemia, 2.7 times greater among infants with 
at least one episode of hyperglycaemia, and 3 times greater in those with at least one episode of 
any glucose derangement (hypoglycaemia or hyperglycaemia) within the first 12 hours compared 
to normoglycaemic infants. Infants with recurrent hypoglycaemia (5% of infants, OR=2.1, 95% 
CI 0.52 to 8.3) and recurrent hyperglycaemia (19% of infants, OR=4.5, 95% CI 1.7 to 12.0) had 
an increased incidence of unfavourable outcome (82% and 77%, respectively), although the 
number of newborns with recurrent glucose abnormalities was small. 
Table 3 Multivariable analysis of association of deranged glucose parameters with unfavourable 
outcome 
 
Deranged glucose parameter within 12 
hours of randomisation 
          Unfavourable outcome 
Adjusted OR            95% CI            p Value 
Hypoglycaemia 6.2 1.4 to 27.3 0.016 
Hyperglycaemia 2.7 1.5 to 4.9 0.001 
Hypoglycaemia or hyperglycaemia 3.0 1.6 to 5.8 0.001 
Both hypoglycaemia and hyperglycaemia  3.5 0.99 to 12.1 0.052 
Recurrent hypoglycaemia 2.1 0.52 to 8.3 0.304 
Recurrent hyperglycaemia 4.5 1.7 to 12.0 0.003 
Recurrent hypoglycaemia and/or 
hyperglycaemia 
2.5 1.4 to 4.2 0.001 
Recurrent hyperglycaemia and/or 
hypoglycaemia 
5.0 1.9 to 13.5 0.001 
Statistical model adjusted for birth weight, hypothermia therapy, Sarnat stage (III vs II),  
Apgar score at 5 minutes, and first pH.
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DISCUSSION 
This study reports systematically collected and analysed evidence that early hypoglycaemia, 
hyperglycaemia, and indeed, any glucose derangement during the early postnatal period, in 
infants with moderate-to-severe HIE are independently associated with an unfavourable outcome 
at 18 months. It is not possible to determine from this exploratory analysis whether this 
association with deranged glucose metabolism is causal. Hypoglycaemia reflects at least in part 
depletion of hepatic glycogen reserves during severe asphyxia, and hepatic injury.[20] Similarly, 
hyperglycaemia may be a proxy for severity of brain injury, as severely damaged tissues show 
reduced net metabolism,[21] or due to prolonged elevation of stress hormones after 
asphyxia.[22] Consistent with the present study, neonatal hyperglycaemia is common in preterm 
and sick infants.[23] The specific mechanisms are likely multifactorial, related to impaired 
insulin response, excessive hepatic glucose production, sepsis, and stress-induced increase in 
counter-regulatory hormones.[24, 25] 
Neonatal hypoglycaemia has been investigated for its association with unfavourable 
neurodevelopmental and academic outcome in term and preterm infants.[26-28] Although the 
definition of neonatal hypoglycaemia has been highly controversial, the American Academy of 
Pediatrics currently recommends early identification of the at-risk infant and institution of 
prophylactic measures to prevent neonatal hypoglycemia.[29] However, only a few studies have 
examined the influence of early hypoglycaemia in infants with HIE on long-term 
neurodevelopmental outcome.[7-9, 30] One study of 60 infants with HIE showed a significant 
association between hypoglycaemia and HIE severity, but did not evaluate longer-term 
outcomes.[9] In another study of 185 term infants with fetal acidemia, investigators observed 
that hypoglycaemia was associated with early abnormal neurologic outcome (i.e., severe HIE 
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and death, moderate-to-severe HIE, and seizures). However, this study did not evaluate outcome 
after hospital discharge.[8] In another study, although early hypoglycaemia was associated with 
adverse outcome at 24 months in 52 term infants with HIE in univariate analysis, hypoglycaemia 
was not a significant predictor after adjustment for severity of HIE.[7] None of the infants 
included in the above studies received therapeutic hypothermia.[7-9] More recently, in a 
prospective cohort study of 94 term infants at risk for neonatal encephalopathy, of whom 12% 
were treated with hypothermia, investigators reported that hypoglycaemia was associated with 
worse motor and cognitive outcome at 1 year.[30]  
There are very limited data describing hyperglycaemia in neonates outside of sick extremely 
premature infants or due to iatrogenic causes, and its relationship with outcome is not clearly 
understood.[23]  A retrospective analysis of 52 term infants with HIE found that hyperglycaemia 
occurred frequently but was not associated with an unfavourable outcome.[7] Conversely, in a 
smaller retrospective study, early hyperglycaemia (in univariate analysis only) in infants with 
HIE was associated with long-term gross motor deficits.[10] We previously reported that mild 
hypothermia was associated with an early increase in mean plasma glucose levels.[18] The 
present study demonstrates that hypoglycaemia as well as hyperglycaemia during the first 12 
hours  were associated with an unfavourable outcome at 18 months age, independent of severity 
of HIE and cooling therapy. 
Our findings are supported by pathophysiologic observations of deranged energy metabolism 
from animal models of asphyxia. During asphyxia, anaerobic glycolysis in the brain increased 
less in hypoglycaemic than normoglycaemic newborn dogs, resulting in more rapid exhaustion 
of high-energy phosphate reserves (phosphocreatine and ATP).[31] Hypoglycaemia selectively 
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impairs cerebrovascular autoregulation by  suppressing adenosine-mediated cerebrovascular 
dilation in newborn piglets.[11]  
Hyperglycaemia during hypoxia-ischaemia or ischaemia increases subsequent brain injury in 
piglets, fetal sheep, and adult rodents.[15-17] In fetal sheep, hyperglycaemia during asphyxia 
reduces cerebral oxygen consumption and increases acidosis.[32] In contrast, post-insult 
treatment has had variable results. Some studies, in neonatal rodents, piglets, and fetal sheep 
have suggested no effect.[16, 33, 34] In contrast, in newborn piglets, hyperglycaemia impaired 
recovery of brain cell membrane function and energy metabolism. [35] Further, hyperglycaemia 
following maternal dexamethasone treatment after asphyxia in fetal sheep was associated with 
increased brain injury.[36] It may be that these contrasting results reflect more adverse effects of 
greater durations of hyperglycaemia, or a deleterious effect of the combination of high levels of 
glucocorticoids with hyperglycaemia. Finally, it is interesting to note that although glucose 
infusion after asphyxial cardiac arrest per se did not increase injury in adult rats, a combined 
glucose and insulin infusion markedly reduced histological brain injury.[37]  
18F-fluorodeoxyglucose positron emission tomography imaging in infants with HIE has 
found deranged glucose metabolism in affected brain areas.[38] Total and regional cerebral 
glucose metabolic rates measured during the subacute period after perinatal asphyxia in term 
infants was inversely correlated with HIE severity and short-term outcome.[39] Magnetic 
resonance imaging on day 3 in infants with HIE and hypoglycaemia suggests that hypoglycaemic 
brain injury was superimposed on patterns of hypoxic ischaemic brain injury.[40]  
Several limitations of the present study should be taken into consideration. The analysis was 
post hoc, and so it is important that the findings are confirmed in prospective studies. We do not 
have glucose values between the pre-defined time points or continuous values and so may have 
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underestimated the true incidence and duration of hypoglycaemia and hyperglycaemia. However, 
the study is strengthened by the regular and systematic determination of glucose levels at discrete 
time points that were not dependent on clinical decisions as in other retrospective studies. 
Glucose infusion rates from parenteral nutrition and intravenous fluids were not standardized 
across subjects, and this information was not available for the present exploratory analysis. 
Further, there was no information regarding treatment thresholds or interventions used, as this 
was not pre-specified by the original study, whether interventions were provided, or how 
interventions to achieve normoglycaemia influenced outcome. Thus, the trend of glucose levels 
towards normoglycaemia over time could represent a response to treatment or more likely, the 
natural history of improving glucose homeostasis in infants with moderate-to-severe HIE. We 
also do not have information on the source (arterial, venous, or capillary) of blood samples, and 
whether different sources of glucose levels could affect interpretation. Future prospective studies 
are needed to further investigate these associations.   
CONCLUSIONS 
Deranged glucose homeostasis was common during the first 12 hours after randomisation in 
infants with moderate-to-severe HIE. Both hypoglycaemia and hyperglycaemia were associated 
with unfavourable outcome at 18 months of age, independent of HIE severity and hypothermia 
treatment. Future studies are needed to investigate whether early deranged glucose metabolism in 
infants with HIE is a biomarker for neuronal injury, has prognostic significance, and aggravates 
further brain injury. 
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Figure legends 
Figure 1 Flow of infants through the trial 
Figure 2 Distribution of glucose values at each time point during the first 12 hours stratified by 
favourable vs unfavourable primary outcome  
Caption: Y-axis depicts percentage of subjects with hyperglycaemia, normoglycaemia, and 
hypoglycaemia at each time point. The n is reported in the columns.  
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Infants assessed for eligibility (n=541) 
Excluded (n= 307) 
 Not meeting inclusion criteria (n= 
271) 
 Declined to participate (n=15) 
 Other reasons (n= 21) 
215 infants included for post hoc analysis 
Randomized to head cooling (n= 116) 
 Received head cooling intervention (n=112) 
 Not cooled (n= 4) 
Randomized to conventional care (n= 
118) 
 1 cooled briefly 
Randomized in CoolCap Study (n= 234) 
Lost to follow-up 
(n=8) 
Glucose data unavailable 
(n=1) 
Lost to follow-up 
(n=8) 
Glucose data unavailable 
(n=2) 
1 infant had no glucose data within first 12 
hours 
214 infants included for univariable analysis 
4 infants had missing Sarnat 
stage 
210 infants included for multivariable analysis 
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